Meda has announced that Orexo's Edluar, a sublingual formulation of zolpidem, gained regulatory approval in Europe. Edluar, which was developed by Orexo using its proprietary sublingual formulation technologies, is indicated for treatment ...
Tags: Regulatory Approval, approval of Edluar, commercial launch